Artikel: Alemtuzumab treatment can affect CD52 positive as well as CD52 negative GPI-deficient Sizary cells allowing long-term disease control

3,03

SKU: product-article-18609 Categorie:

Beschrijving

Alemtuzumab treatment can affect CD52 positive as well as CD52 negative GPI-deficient Sizary cells allowing long-term disease control